Sign In
Buy NTEC
$2.05
+0 (+0%)
At Close: Aug 17, 2022
Intec Pharma Provides Update on Novartis Feasibility and Option Agreement
12:30pm, Wednesday, 11'th Dec 2019
Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces the termination of the Feasibility and Option agreement with Novartis for the development of a custom-designed Accordion Pil
Intec Pharma to Present at LD Micro's 12th Annual Main Event
12:30pm, Friday, 06'th Dec 2019
Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company management will be participating in the 12th Annual LD Micro Main Event investor conference.
Intec Pharma Announces $10 Million Ordinary Shares Purchase Agreement With Aspire Capital
12:30pm, Tuesday, 03'rd Dec 2019
Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company has entered into an Ordinary Shares Purchase Agreement for $10.0 million with Aspire Capital Fund, LLC ("As
Intec Pharma to Participate in Jefferies London Healthcare Conference
12:00pm, Wednesday, 13'th Nov 2019
JERUSALEM, Nov. 13, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces that Company management will participate in the Jefferies London Healthcare Conference. Mr
Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update
12:00pm, Tuesday, 12'th Nov 2019
JERUSALEM , Nov. 12, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and nine months ended September ...
JERUSALEM , Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 ...
Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society
11:00am, Monday, 16'th Sep 2019
JERUSALEM , Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical ...
Intec Pharma to Participate in September Investment Conferences
11:00am, Tuesday, 03'rd Sep 2019
JERUSALEM, Sept. 3, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences i
